Ergoteles’s Milestone Scientific MLSS Stock Holding History

Ergoteles’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-207,117	Closed	-$387K	–	1463
2021 Q3	$387K	Sell	207,117 -2,283	-1%	-$4.22K	0.01%	694
2021 Q2	$513K	Buy	+209,400	New	+$508K	0.01%	793

Other funds holding MLSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ergoteles's MLSS Position: Q4 2021 in Review

Ergoteles sold out of Milestone Scientific (MLSS) in Q4 2021, closing a stake of 207,117 shares — an estimated $387K sold.

Ergoteles first reported a position in MLSS in Q2 2021 and held it in 2 quarters. The position peaked at $513K in Q2 2021. 37 funds tracked by Wall St. Rank hold MLSS as of Q4 2021.

Ergoteles reported no remaining Milestone Scientific position as of Q4 2021 after selling out during the quarter.
Ergoteles sold 207,117 Milestone Scientific shares in Q4 2021, an estimated $387K.
Ergoteles first reported a position in Milestone Scientific in Q2 2021 and held it in 2 quarters.
Ergoteles's Milestone Scientific position peaked at $513K in Q2 2021.
37 funds tracked by Wall St. Rank held Milestone Scientific as of Q4 2021.

Based on Ergoteles's 13F filing for Q4 2021, filed 14 Feb 2022.